LFST - Public offerings

SCOTTSDALE, Ariz., Sept. 09, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. ("LifeStance" or the "Company") (NASDAQ:LFST), one of the nation’s largest providers of virtual and in-person outpatient mental health care, today announced the pricing of a secondary underwritten public offering of 22,250,000 shares of LifeStance’s common stock, par value $0.01 per share (the "Common Stock") at a public offering price of $12.35 per share, pursuant to a shelf registration statement filed with the Securities and Exchange Commission (the "SEC") from certain stockholders of the Company (the "Selling Stockholders"). The Selling Stockholders will receive all of the proceeds from the offering. Th

SCOTTSDALE, Ariz., Sept. 09, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. ("LifeStance" or the "Company") (NASDAQ:LFST), one of the nation’s largest providers of virtual and in-person outpatient mental health care, today announced that pursuant to a shelf registration statement filed with the Securities and Exchange Commission (the "SEC"), certain stockholders of the Company (the "Selling Stockholders") intend to offer 22,250,000 shares of LifeStance’s common stock, par value $0.01 per share (the "Common Stock"). The Selling Stockholders will receive all of the proceeds from the offering. The Company is not selling any shares of Common Stock in the offering and will not receive a

SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. ("LifeStance" or the "Company") (NASDAQ:LFST), one of the nation's largest providers of virtual and in-person outpatient mental health care, today announced the pricing of a secondary underwritten public offering of 35,000,000 shares of LifeStance's common stock, par value $0.01 per share (the "Common Stock") at a public offering price of $8.15 per share, pursuant to a shelf registration statement filed with the Securities and Exchange Commission (the "SEC") from certain stockholders of the Company (the "Selling Stockholders"). The Selling Stockholders will receive all of the proceeds from the offering. The C

SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. ("LifeStance" or the "Company") (NASDAQ:LFST), one of the nation's largest providers of virtual and in-person outpatient mental health care, today announced that pursuant to a shelf registration statement filed with the Securities and Exchange Commission (the "SEC"), certain stockholders of the Company (the "Selling Stockholders") intend to offer 35,000,000 shares of LifeStance's common stock, par value $0.01 per share (the "Common Stock"). The Selling Stockholders will receive all of the proceeds from the offering. The Company is not selling any shares of Common Stock in the offering and will not receive any

SCOTTSDALE, Ariz., Feb. 25, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. ("LifeStance" or the "Company") (NASDAQ:LFST), one of the nation's largest providers of virtual and in-person outpatient mental health care, today announced that pursuant to a shelf registration statement filed with the Securities and Exchange Commission (the "SEC"), certain stockholders of the Company (the "Selling Stockholders") intend to offer 25,000,000 shares of LifeStance's common stock, par value $0.01 per share (the "Common Stock"). The Selling Stockholders will receive all of the proceeds from the offering. The Company is not selling any shares of Common Stock in the offering and will not receive an

SCOTTSDALE, Ariz., May 21, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. ("LifeStance" or the "Company") (NASDAQ:LFST), one of the nation's largest providers of virtual and in-person outpatient mental health care, today announced the pricing of a secondary underwritten public offering of 20,000,000 shares of LifeStance's common stock, par value $0.01 per share (the "Common Stock") at a public offering price of $6.25 per share, pursuant to a shelf registration statement filed with the Securities and Exchange Commission (the "SEC"). The underwriters will have a 30-day option to purchase up to an additional 3,000,000 shares of Common Stock from certain stockholders of the Company (th

SCOTTSDALE, Ariz., May 21, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. ("LifeStance" or the "Company") (NASDAQ:LFST), one of the nation's largest providers of virtual and in-person outpatient mental health care, today announced that certain stockholders of the Company (the "Selling Stockholders") intend to offer 20,000,000 shares of LifeStance's common stock, par value $0.01 per share (the "Common Stock"), pursuant to a shelf registration statement filed with the Securities and Exchange Commission (the "SEC"). The underwriters will have a 30-day option to purchase up to an additional 3,000,000 shares of common stock from the Selling Stockholders. The Selling Stockholders will re

SCOTTSDALE, Ariz., March 08, 2023 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results for the fourth quarter and full year ended December 31, 2022. (All results compared to prior-year comparative period, unless otherwise noted)2022 Highlights and 2023 Outlook Fourth quarter revenue increased 21% to $229.4 million and full year revenue of $859.5 million increased $192.0 million or 29% compared to revenue of $667.5 millionClinician base increased 18% to 5,631 clinicians, including 200 net clinician adds in the fourth quarter and 841 for the full yearNet loss of $46.7 millio

SCOTTSDALE, Ariz., Nov. 08, 2022 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results for the quarter ended September 30, 2022. (All results compared to prior-year comparative period, unless otherwise noted) Q3 2022 Highlights and FY 2022 Outlook Revenue of $217.6 million increased $43.8 million or 25% compared to revenue of $173.8 millionTotal clinicians of 5,431 up 24%, a net increase of 205 in the third quarterNet loss of $37.9 million compared to net loss of $120.5 million, primarily driven by stock-based compensation expense of $34.9 millionAdjusted EBITDA of positiv

SCOTTSDALE, Ariz., Aug. 09, 2022 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, today announced financial results for the quarter ended June 30, 2022. (All results compared to prior-year comparative period, unless otherwise noted)Q2 2022 Highlights and FY 2022 Outlook Revenue of $209.5 million increased $49.0 million or 31% compared to revenue of $160.5 millionTotal clinicians of 5,226 up 31%, a net increase of 237 in the second quarterNet loss of $68.7 million compared to net loss of $70.0 million, primarily driven by stock-based compensation expense of $57.5 millionAdjusted EBITDA of positive $14.

SCOTTSDALE, Ariz., March 10, 2022 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, today announced financial results for the fourth quarter and full year ended December 31, 2021. (All results compared to prior-year comparative period, unless otherwise noted)2021 Highlights and 2022 Outlook Fourth quarter revenue increased 61% to $190.1 million and full year revenue of $667.5 million increased $290.3 million or 77%1 compared to revenue of $377.2 million in 2020 ($265.5 million for the Successor 2020 Period and $111.7 million for the Predecessor 2020 Period)Clinician base increased 55% to 4,790 clin

Third Quarter 2021 Highlights(All results compared to prior-year comparative period, unless otherwise noted) Revenue of $173.8 million increased $71.8 million or 70% compared to revenue of $102.0 millionTotal clinicians of 4,375 up 72%, a net increase of 400 clinicians in the third quarterNet loss of $120.5 million compared to net loss of $3.3 million, primarily driven by stock and unit-based compensationAdjusted EBITDA of $10.7 million compared to Adjusted EBITDA of $15.0 millionExpecting full year revenue toward the lower end of previously guided $668 million to $678 million range; Center Margin and Adjusted EBITDA expectations remain unchanged; anticipated incremental clinician holiday t

SCOTTSDALE, Ariz., Aug. 11, 2021 /PRNewswire/ --  Second Quarter 2021 Highlights Revenue of $160.5 million increased $76.5 million or 91%1 compared to revenue of $38.6 million for the period from April 1, 2020 to May 14, 2020 (Predecessor) and $45.4 million for the period from April 13, 2020 to June 30, 2020 (Successor) Total clinicians of 3,975 up 94% year over year, including 674 net clinician adds in the second quarter Net loss was $70.0 million compared to net loss of $27.6 million for the period from April 1, 2020 to May 14, 2020 (Predecessor) and $4.3 million for the per